Sachetta’s Collegium Pharmaceutical COLL Stock Holding History

Sachetta’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24	Closed	-$739	–	1244
2024 Q1	$739	Hold	24	–	–	﹤0.01%	993
2023 Q4	$739	Buy	+24	New	+$601	﹤0.01%	993

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Sachetta's COLL Position: Q2 2024 in Review

Sachetta sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 24 shares — an estimated $739 sold.

Sachetta first reported a position in COLL in Q4 2023 and held it in 2 quarters. The position peaked at $739 in Q1 2024. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.

Sachetta reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Sachetta sold 24 Collegium Pharmaceutical shares in Q2 2024, an estimated $739.
Sachetta first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 2 quarters.
Sachetta's Collegium Pharmaceutical position peaked at $739 in Q1 2024.
229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.

Based on Sachetta's 13F filing for Q2 2024, filed 7 Aug 2024.